Suchergebnisse - "Sanchez-Arraez, Alvaro"

PubPharm (6)

1

Bayesian interpretation of immunotherapy trials with dynamic treatment effects

enthalten in: European journal of cancer (Oxford, England : 1990) | 2022

von Castañon, E. | Sanchez-Arraez, �. | Jimenez-Fonseca, P. | +4

2

Erratum to "Critical reappraisal of phase III trials with immune checkpoint inhibitors in non-proportional hazards settings" [Eur J Cancer 136 (September 2020) 159-168

enthalten in: European journal of cancer (Oxford, England : 1990) | 2021

von Castañón, E. | Sanchez-Arraez, A. | Alvarez-Manceñido, F. | +2

ErratumFor: Eur J Cancer. 2020 Sep;136:159-168. - PMID 32698098

3

Critical reappraisal of phase III trials with immune checkpoint inhibitors in non-proportional hazards settings

enthalten in: European journal of cancer (Oxford, England : 1990) | 2020

von Castañon, E. | Sanchez-Arraez, A. | Alvarez-Manceñido, F. | +2

ErratumIn: Eur J Cancer. 2020 Nov 5;:. - PMID 33162285

4

Does active smoking worsen Covid-19?

enthalten in: European journal of internal medicine | 2020

von Carmona-Bayonas, A. | Jimenez-Fonseca, P. | Sánchez Arraez, �. | +2

CommentOn: Eur J Intern Med. 2020 May;75:107-108. - PMID 32192856

5

Intratumoral Immunotherapy with XCL1 and sFlt3L Encoded in Recombinant Semliki Forest Virus-Derived Vectors Fosters Dendritic Cell-Mediated T-cell Cross-Priming

enthalten in: Cancer research | 2018

von Sánchez-Paulete, A. | Teijeira, �. | Quetglas, J. | +13

6

Cellular immunotherapies for cancer

enthalten in: Oncoimmunology | 2017

von Berraondo, P. | Labiano, S. | Minute, L. | +5

1
[1]